Literature DB >> 16628830

Funding for accelerating drug development initiative critical.

Joanna Owens.   

Abstract

Mesh：

Year:  2006        PMID： 16628830     DOI： 10.1038/nrd2015

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  5 in total

1.  [Serum-based biomarkers for psychiatric disorders].

Authors:  S Bahn; E Schwarz
Journal:  Nervenarzt       Date:  2011-11       Impact factor: 1.214

2.  A novel approach to the use of animals in studies of pain: validation of the canine brief pain inventory in canine bone cancer.

Authors:  Dorothy Cimino Brown; Raymond Boston; James C Coyne; John T Farrar
Journal:  Pain Med       Date:  2008-09-24       Impact factor: 3.750

3.  The application of selective reaction monitoring confirms dysregulation of glycolysis in a preclinical model of schizophrenia.

Authors:  Daniel Martins-de-Souza; Murtada Alsaif; Agnes Ernst; Laura W Harris; Nancy Aerts; Ilse Lenaerts; Pieter J Peeters; Bob Amess; Hassan Rahmoune; Sabine Bahn; Paul C Guest
Journal:  BMC Res Notes       Date:  2012-03-15

4.  MK-801 treatment affects glycolysis in oligodendrocytes more than in astrocytes and neuronal cells: insights for schizophrenia.

Authors:  Paul C Guest; Keiko Iwata; Takahiro A Kato; Johann Steiner; Andrea Schmitt; Christoph W Turck; Daniel Martins-de-Souza
Journal:  Front Cell Neurosci       Date:  2015-05-12       Impact factor: 5.505

Review 5.  Proteomic profiling in schizophrenia: enabling stratification for more effective treatment.

Authors:  Paul C Guest; Daniel Martins-de-Souza; Emanuel Schwarz; Hassan Rahmoune; Murtada Alsaif; Jakub Tomasik; Christoph W Turck; Sabine Bahn
Journal:  Genome Med       Date:  2013-03-26       Impact factor: 11.117
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.